GlassScriptPhysician profile
Kyle Huntsman
NPI 1619437977
$4,484.25
in general payments reported to CMS, 2019-2025
12 companies · $507 in 2025
The $507 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,016 · 2023: $723 · 2024: $1,238 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,175 · Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,175.49 |
| Food and Beverage | $292.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $1,200.00 | 2022 | |
| Medshape, INC. | $786.46 | 2024 | Dynanail, Dynanail Hybrid, Dynanail Helix, Washer, 15 Mm |
| International Life Sciences | $722.97 | 2023 | |
| Arthrex, INC. | $482.45 | 2025 | |
| Tricoast Surgical Solutions LLC | $448.98 | 2024-2025 | |
| Smith+Nephew, INC. | $264.70 | 2022 | |
| Bioventus LLC | $164.62 | 2022 | |
| Heron Therapeutics, INC. | $132.00 | 2022 | |
| Advanced Oxygen Therapy INC. | $124.99 | 2022 | |
| Paratek Pharmaceuticals, INC. | $104.87 | 2022 | |
| Restor3d, INC. | $27.17 | 2024 | |
| Integra Lifesciences Corporation | $25.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Huntsman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.